Literature DB >> 7122329

Computerized image analysis of nuclear shape as a prognostic factor for prostatic cancer.

D A Diamond, S J Berry, C Umbricht, H J Jewett, D S Coffey.   

Abstract

Computer assisted image analysis was used to determine quantitative and reproducible nuclear morphology of 17 totally excised pathological specimens from stage B-2 prostatic cancer in an attempt to correlate histopathological analysis with clinical prognosis for the individual patient. We describe a nuclear roundness factor that correlates with the clinical outcome of the individual patient. This nuclear shape factor appears to identify prostatic tumors with a high metastatic potential from tumors that are less aggressive. Quantitative nuclear image analysis, its accuracy, and reproducibility are described and discussed. This technique may provide the pathologist with a valuable tool for analyzing prostatic cancer cells in a quantitative manner, thereby contributing precise information to the urologist relevant to the prognosis of the individual patient.

Entities:  

Mesh:

Year:  1982        PMID: 7122329     DOI: 10.1002/pros.2990030402

Source DB:  PubMed          Journal:  Prostate        ISSN: 0270-4137            Impact factor:   4.104


  23 in total

Review 1.  Nuclear morphometry, nucleomics and prostate cancer progression.

Authors:  Robert W Veltri; Christhunesa S Christudass; Sumit Isharwal
Journal:  Asian J Androl       Date:  2012-04-16       Impact factor: 3.285

2.  Quantitative characterization of preneoplastic progression using single-cell computed tomography and three-dimensional karyometry.

Authors:  Vivek Nandakumar; Laimonas Kelbauskas; Roger Johnson; Deirdre Meldrum
Journal:  Cytometry A       Date:  2011-01       Impact factor: 4.355

3.  Computational image analysis of nuclear morphology associated with various nuclear-specific aging disorders.

Authors:  Siwon Choi; Wei Wang; Alexandrew J S Ribeiro; Agnieszka Kalinowski; Siobhan Q Gregg; Patricia L Opresko; Laura J Niedernhofer; Gustavo K Rohde; Kris Noel Dahl
Journal:  Nucleus       Date:  2011-11-01       Impact factor: 4.197

4.  Computational Staining of Pathology Images to Study the Tumor Microenvironment in Lung Cancer.

Authors:  Shidan Wang; Ruichen Rong; Donghan M Yang; Junya Fujimoto; Shirley Yan; Ling Cai; Lin Yang; Danni Luo; Carmen Behrens; Edwin R Parra; Bo Yao; Lin Xu; Tao Wang; Xiaowei Zhan; Ignacio I Wistuba; John Minna; Yang Xie; Guanghua Xiao
Journal:  Cancer Res       Date:  2020-01-08       Impact factor: 12.701

5.  Morphometrically estimated variation in nuclear size. A useful tool in grading prostatic cancer.

Authors:  J H Blom; F J Ten Kate; F H Schroeder; R O van der Heul
Journal:  Urol Res       Date:  1990

6.  Accumulation of iron by primary rat hepatocytes in long-term culture: changes in nuclear shape mediated by non-transferrin-bound forms of iron.

Authors:  E E Cable; J R Connor; H C Isom
Journal:  Am J Pathol       Date:  1998-03       Impact factor: 4.307

7.  Evaluation of diagnostic efficiency of computerized image analysis based quantitative nuclear parameters in papillary and follicular thyroid tumors using paraffin-embedded tissue sections.

Authors:  N Gupta; C Sarkar; R Singh; A K Karak
Journal:  Pathol Oncol Res       Date:  2001       Impact factor: 3.201

8.  The relationship of quantitative nuclear morphology to molecular genetic alterations in the adenoma-carcinoma sequence of the large bowel.

Authors:  J W Mulder; G J Offerhaus; E P de Feyter; J J Floyd; S E Kern; B Vogelstein; S R Hamilton
Journal:  Am J Pathol       Date:  1992-10       Impact factor: 4.307

9.  Long-term assessment of prostate cancer progression free survival: evaluation of pathological parameters, nuclear shape and molecular biomarkers of pathogenesis.

Authors:  Robert W Veltri; Sumit Isharwal; M Craig Miller; Jonathan I Epstein; Leslie A Mangold; Elizabeth Humphreys; Alan W Partin
Journal:  Prostate       Date:  2008-12-01       Impact factor: 4.104

10.  Using nuclear morphometry to predict the need for treatment among men with low grade, low stage prostate cancer enrolled in a program of expectant management with curative intent.

Authors:  Danil V Makarov; Cameron Marlow; Jonathan I Epstein; M Craig Miller; Patricia Landis; Alan W Partin; H Ballentine Carter; Robert W Veltri
Journal:  Prostate       Date:  2008-02-01       Impact factor: 4.104

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.